Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 856777 | ISIN: ZAE000018123 | Ticker-Symbol: EDGA
Tradegate
17.01.25
21:34 Uhr
14,900 Euro
+0,150
+1,02 %
Branche
Rohstoffe
Aktienmarkt
AFRIKA
1-Jahres-Chart
GOLD FIELDS LIMITED Chart 1 Jahr
5-Tage-Chart
GOLD FIELDS LIMITED 5-Tage-Chart
RealtimeGeldBriefZeit
14,70014,90017.01.
14,65014,85017.01.
ACCESS Newswire
442 Leser
Artikel bewerten:
(2)

Torq Resources Inc.: Torq Resources Announces Santa Cecilia Option and Joint Venture Transaction with Gold Fields Now In Effect

Finanznachrichten News

VANCOUVER, BC / ACCESS Newswire / January 17, 2025 / Torq Resources Inc. (TSXV:TORQ)(OTCQB:TRBMF) ("Torq" or the "Company") is pleased to announce the finalization of the previously announced earn-in option and joint venture transaction involving the Company's Santa Cecilia project in Chile (the "Project"). The option and joint venture transaction is with an affiliate of Gold Fields Limited ("Gold Fields") and by which Gold Fields has acquired a staged option to earn into up to a 75% indirect interest in the project by funding up to USD$48 million over a period of up to 6 years of which a committed minimum spend of USD$6 million will earn Gold Fields an initial 10% interest. Further to the Implementation Agreement entered into on November 29, 2024, as amended on January 9, 2025, the parties entered into an option and joint venture shareholders agreement (the "OJVSA") and a related Chilean formal option agreement (the "Chilean Option Agreement") to give effect to the option and joint venture transaction. The parties have also made minor conforming amendments to the investment agreement between Torq and another affiliate of Gold Fields (the "Investment Agreement Amendment"). Torq will file the executed OJVSA, Chilean Option Agreement and Investment Agreement Amendment (together, the "Definitive Agreements") on SEDAR+ together with its material change report disclosing completion of the transaction.

A disinterested majority of Torq shareholders overwhelmingly approved the transaction at a special and annual shareholders meeting held on January 10, 2025 by the Company. The common shares of Torq held by Gold Fields were excluded from voting in accordance with the disinterested vote requirements under Multilateral Instrument 61-101 - Protection of Minority Security Holders in Special Transactions ("MI 61- 101") and TSX Venture Exchange policies because Gold Fields constitutes a "related party" by virtue of Gold Fields' current approximately 14.9% shareholding in Torq. Final transaction conditions were fulfilled and the Definitive Agreement executed on January 17, 2025. The Company relied on the exemption from the formal valuation requirements under Section 5.5(b) of Part 5 of MI 61-101 as a result of being solely listed on the TSX Venture Exchange.

Under the Definitive Agreements, Gold Fields has acquired the initial option to earn up to a 51% interest in the Project by funding an aggregate of US$18 million of Project expenses, including exploration expenditures, property payments and other like expenses within the first 30 months of closing under the Definitive Agreements. Of this US$18 million amount, US$6 million is a committed minimum spend after which Gold Fields will have earned an initial 10% interest. Gold Fields may thereafter earn an additional 41% interest in the Project by funding a further US$12 million of exploration expenditures by the end of the 30 months, and a further 24% interest (total 75%) by incurring, as operator, a final US$30 million during the following 42 months (total of 6 years).

Under an interim bridge loan agreement with Gold Fields which was announced by Torq on October 18, 2024, Gold Fields has advanced approximately US$1.8 million as interim loans to Torq. These interim loans have now been converted to a contingent capital contribution on account of the advance of exploration expenditures required under the initial option and minimum $6 million commitment and the interim loan is no longer outstanding.

Shawn Wallace, Torq CEO commented "With preparatory work for project drilling well advanced, the completion of this transaction is very timely. We are off to an exciting start to 2025 at Santa Cecilia."

ON BEHALF OF THE BOARD,

Shawn Wallace
CEO & Chair

For further information on Torq Resources, please visit www.torqresources.com or contact the company at (778) 729-0500 or info@torqresources.com.

About Torq Resources

Torq is a Vancouver-based copper and gold exploration company with a portfolio of premium holdings in Chile. The Company is establishing itself as a leader of new exploration in prominent mining belts, guided by responsible, respectful and sustainable practices. The Company was built by a management team with prior success in monetizing exploration assets and its specialized technical team is recognized for their extensive experience working with major mining companies, supported by robust safety standards and technical proficiency. The technical team includes Chile-based geologists with invaluable local expertise and a noteworthy track record for major discovery in the country. Torq is committed to operating at the highest standards of applicable environmental, social and governance practices in the pursuit of a landmark discovery. For more information, visit www.torqresources.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Torq Resources Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.